Rare-Cell Biology™
Rare-Cell Biology™
Revealing the Rare Cells That Shape Human Health
Ultrasensitive detection, single-cell profiling, and biological intelligence to advance precision diagnostics and therapies.
01CellsBin Scout™
See the Rare Therapeutic Cells That Drive Outcomes
Detect, quantify and phenotype every single therapeutic cell over time.
02CellsBin Insight™
Marrow-Level Insights from Rare Malignant Cells in Blood
Get marrow-level sensitivity from a routine blood draw.
03CellsBin Polaris™
A Platform for the Future of Precision Medicine
The scalable foundation behind rare-cell detection, biology, and intelligence.
Pioneering
Rare-Cell Biology™
Rare cell insights can shape disease diagnosis and inform therapy response, disease progression, recurrence, immune state, and clinical outcomes. CellsBin detects and analyzes these cells with best-in-class sensitivity, translating biological into actionable insights across research and medicine.
Scientific Evidence and Publications
View PublicationsASCO 2026: Assessment of long-term persistence and phenotypic features of BCMA CAR-T cells in patients with relapsed or refractory multiple myeloma treated with ciltacabtagene autoleucel.
ASCO 2026: Blinded comparison of natural killer cell detection with AI-driven nanophotonic imaging versus traditional spectral flow cytometry: Development of the CB-Scout assay
S'Wipe: user-friendly stool collection for high-throughput gut metabolomics and multi-omics
Partner With CellsBin
For biopharma, clinical, translational, and technology collaborators advancing rare-cell biology.
Scientific collaboration
Work together on rare-cell biology, translational strategy, and biomarker-driven programs.
Clinical visibility
Generate deeper insight into therapy-cell persistence, tumor-cell dynamics, phenotype, and response.
Platform integration
Leverage CellsBin's technology stack to support research, development, and clinical studies.
Shared impact
Build partnerships that accelerate smarter decisions and better patient outcomes.
Trusted by leading research & clinical partners
